Redmile Group LLC

Search
⚲

Message
Happy Holidays!! thanks for using AUM13F!!

Redmile Group LLC ✚
CRD #	143606
SEC #	801-67747
CIK #	0001425738
AUM	$4.8 B (2025-03-31)
Employees	30 (43% Investors, 0% Brokers)
Phone	415-489-9980
Address	One Letterman Drive San Francisco, CA 94129
Source	[IAPD] [EDGAR] [Website]

Total AUM ($B) Copy

CIK	Period
0001425738	2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31

CIK

Period

0001425738

Sector	Form 13F Holdings	Value ($B)
	Scholar Rock Holding Corp	0.1
	Krystal Biotech Inc	0.1
	Zymeworks Inc	0.1
	Stoke Therapeutics Inc	0.0
	Immunome Inc	0.0
	Replimune Group Inc	0.0
	Nurix Therapeutics Inc	0.0
	Livanova PLC	0.0
	ADC Therapeutics Sa	0.0
	Akero Therapeutics Inc	0.0
	RegenxBio Inc	0.0
	Kymera Therapeutics Inc	0.0
	Beam Therapeutics Inc	0.0
	Absci Corp	0.0
	Aquinox Pharmaceuticals Inc	0.0
	89bio Inc	0.0
	Annexon Inc	0.0
	Fate Therapeutics Inc	0.0
	Silence Therapeutics PLC	0.0
	UNUM Therapeutics Inc	0.0
	Biohaven Ltd	0.0
	Solid Biosciences Inc	0.0
	Boston Scientific Corp	0.0
	IDEAYA Biosciences Inc	0.0
	Ceribell Inc	0.0
	Keros Therapeutics Inc	0.0
	Celldex Therapeutics Inc	0.0
	Amicus Therapeutics Inc	0.0



Prev \| Page 1 \| Next

Type	Form D Funds	Date	Sold ($M)	AUM ($M)
HF	Redmile Strategic Long Only Trading Sub Ltd	[2022-08-15]	498.5	219.8
HF	Redmile Strategic Trading Sub Ltd	[2022-08-15]	498.5	145.7
VC	Redmile Growth Investments I LP	[2022-02-09]	122.0	38.8
PE	RM Special Holdings 8 LLC	2022-02-09		0.6
HF	Redco II Master Fund LP	[2021-03-31]	31.4	1,589.9
PE	Redmile Biopharma Investments III LP	[2021-02-26]	500.2	972.2
PE	RM Special Holdings 4 LLC	2021-02-26		0.0
HF	Redco I LP	[2020-08-27]	187.5	38.8
VC	Redmile Biopharma Investments II LP	[2019-03-29]	675.4	657.6
HF	Redmile Capital Offshore II Master Fund Ltd	2019-03-29		845.8
View All

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	26	4.8
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	26	4.8
By Discretionary
Discretionary	26	4.8
Non-Discretionary	0	0.0
Total	26	4.8
By Non-United States Persons
Non-United States Persons		3.3
United States Persons		1.5
Total	26	4.8

Form D Directors	# Filings	# Firms	2011 - 2025
Ronan Guilfoyle	355
Roger Hanson	255
Vijayabalan Murugesu	126
Philip Hughes	86
Mike Lee	20
Gerard van Hamel Platerink	19
Jeremy Green	16
Redmile Group LLC	10
Amrit Nagpal	10
Rob Faulkner	3
View All

EDGAR Form	CIK	2011 - 2025
13F-HR	[0001425738]
3	[0001425738]
4	[0001425738]
SC 13D	[0001425738]
SC 13G	[0001425738]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Redmile Group LLC	Atara Biotherapeutics Inc	[2025-05-23]
Redmile Group LLC	Silence Therapeutics PLC	[2025-02-14]
Redmile Group LLC	Pliant Therapeutics Inc	[2024-11-14]
Redmile Group LLC	RegenxBio Inc	[2023-11-17]
Redmile Group LLC	ALX Oncology Holdings Inc	[2023-10-16]
Redmile Group LLC	Immunome Inc	[2023-10-12]
Redmile Group LLC	Neoleukin Therapeutics Inc	[2023-07-27]
Redmile Group LLC	Akero Therapeutics Inc	[2023-02-14]
Redmile Group LLC	Ayala Pharmaceuticals Inc	[2023-02-08]
Redmile Group LLC	Zymeworks Inc	[2022-10-17]
View All

Form 3/4/5 Subject	2011 - 2025
IGM Biosciences, Inc.
Redmile Group, LLC
Green Jeremy
Shattuck Labs, Inc.
ADC Therapeutics SA
RedCo II Master Fund, L.P.
Fate Therapeutics Inc
Atara Biotherapeutics, Inc.
Augmedix, Inc.
Redmile Private Investments II, L.P.
View All

Comparable Firms	State	AUM ($B)
MHR Fund Management LLC ✚	NY	5.2
Matrix Capital Management Company LP ✚	NH	5.0
Senator Investment Group LP ✚	NY	5.0
Anchorage Capital Group LLC ✚	NY	4.9
Brinley Partners LP ✚	NY	4.7
Peak Rock Capital LLC ✚	TX	4.6
First Sentier Infrastructure Managers International Limited ✚		4.5
Victory Park Capital Advisors LLC ✚	IL	4.5
XN LP ✚	NY	4.5
JC Flowers & Co LLC ✚	NY	4.4

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}

Redmile Group LLC

Assets, Funds, Holdings